SEELOS THERAPEUTICS, INC.

/SEELOS THERAPEUTICS, INC.

Follow-on

SEELOS THERAPEUTICS, INC.

Biopharmaceutical

We are a clinical-stage biopharmaceutical company focused on achieving efficient development of products that address significant unmet needs in Central Nervous System ("CNS") disorders and other rare disorders.

Symbol

SEEL

Last Closing Price
$1.09

Shares
5,500,000

Anticipated Date
February 11, 2020

Underwriters
THE BENCHMARK COMPANY, LLC

This offering is no longer available

To view the prospectus for SEELOS THERAPEUTICS, INC., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277